FTC OKs Stryker's $4B Wright Medical Deal, With Divestitures
The Federal Trade Commission is requiring medical device company Stryker Corp. to divest all its ankle replacement and finger joint implant products before going forward with its slated $4 billion acquisition...To view the full article, register now.
Already a subscriber? Click here to view full article